Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Acute Ischemic Stroke
Clinical trial NCT05993884 · COMPLETED
Trial details
- NCT number
- NCT05993884
- Sponsor
- Allife Medical Science and Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-24
- Primary completion
- 2025-04-15
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.